Evidence map›Paper›PMID 21818335›Full record

ArticlePloS one2011

Control of gene expression by the retinoic acid-related orphan receptor alpha in HepG2 human hepatoma cells.

Caroline Chauvet, Amandine Vanhoutteghem, Christian Duhem, Gaëlle Saint-Auret, Brigitte Bois-Joyeux, Philippe Djian, Bart Staels, Jean-Louis Danan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Microorganisms · 2021
    Article
  11. Article
  12. Article
  13. OncoTargets and therapy · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Retinoic acid receptor-related receptor alpha (RORalpha) is a prognostic marker for hepatocellular carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Caroline ChauvetLaboratoire de Pharmacologie, Toxicologie et Signalisation Cellulaire, INSERM UMR-S-747, Centre Universitaire des Saints Pères, Université Paris Descartes, Paris, France. caroline.chauvet@parisdescartes.fr
Amandine Vanhoutteghem
Christian Duhem
Gaëlle Saint-Auret
Brigitte Bois-Joyeux
Philippe Djian
Bart Staels
Jean-Louis Danan
Délégation Paris 5 · FRInstitut Pasteur de Lille · FRUniversité Paris Cité · FRInserm · FRToxicologie, Pharmacologie et Signalisation Cellulaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinoic acid-related Orphan Receptor alpha (RORα; NR1F1) is a widely distributed nuclear receptor involved in several (patho)physiological functions including lipid metabolism, inflammation, angiogenesis, and circadian rhythm. To better understand the role of this nuclear receptor in liver, we aimed at displaying genes controlled by RORα in liver cells by generating HepG2 human hepatoma cells stably over-expressing RORα. Genes whose expression was altered in these cells versus control cells were displayed using micro-arrays followed by qRT-PCR analysis. Expression of these genes was also altered in cells in which RORα was transiently over-expressed after adenoviral infection. A number of the genes found were involved in known pathways controlled by RORα, for instance LPA, NR1D2 and ADIPOQ in lipid metabolism, ADIPOQ and PLG in inflammation, PLG in fibrinolysis and NR1D2 and NR1D1 in circadian rhythm. This study also revealed that genes such as G6PC, involved in glucose homeostasis, and AGRP, involved in the control of body weight, are also controlled by RORα. Lastly, SPARC, involved in cell growth and adhesion, and associated with liver carcinogenesis, was up-regulated by RORα. SPARC was found to be a new putative RORα target gene since it possesses, in its promoter, a functional RORE as evidenced by EMSAs and transfection experiments. Most of the other genes that we found regulated by RORα also contained putative ROREs in their regulatory regions. Chromatin immunoprecipitation (ChIP) confirmed that the ROREs present in the SPARC, PLG, G6PC, NR1D2 and AGRP genes were occupied by RORα in HepG2 cells. Therefore these genes must now be considered as direct RORα targets. Our results open new routes on the roles of RORα in glucose metabolism and carcinogenesis within cells of hepatic origin.

Indexed as

Gene Expression Regulation, NeoplasticAdenoviridaeBase SequenceCarcinoma, HepatocellularChromatin ImmunoprecipitationHep G2 CellsHumansLiver NeoplasmsMolecular Sequence DataNeoplasm ProteinsNuclear Receptor Subfamily 1, Group F, Member 1Oligonucleotide Array Sequence AnalysisOsteonectinProtein BindingResponse ElementsReverse Transcriptase Polymerase Chain ReactionNeoplasm ProteinsNuclear Receptor Subfamily 1, Group F, Member 1OsteonectinRORA protein, human

Identifiers

PMID21818335
PMCPMC3144224
OpenAlexW2073395521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.